Pdl Biopharma Inc (PDLI)

EBITDA Margin

-2091.50%

TTM · Period ending:

PDLI logo

PDLI EBITDA Margin

Latest reported-2091.50%
PDLI TTM EBITDA Margin (-71.01% → -2091.50%)
High-resolution chart · PNG

PDLI ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Pdl Biopharma Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-2,091.4988%
-257.7154%
-521.2968%
-100.7013%
35.4841%
71.4203%
-13.4341%
-14.2686%
-10.3653%
-12.3526%
72.3767%
75.9087%
61.8936%
65.1262%
44.4572%
65.2781%
96.3558%
96.9416%
99.8561%
100.5397%
100.2063%
102.8627%
100.0173%
99.1793%
99.9806%
97.4307%
98.198%
97.621%
96.801%
97.0974%
96.3625%
95.3514%
94.7778%
94.783%
94.84%
95.2751%
68.2414%
65.832%
59.9342%
56.3023%
83.8437%
85.7905%
92.64%
94.484%
95.3714%
93.7452%
72.4889%
37.4197%
45.3742%
8.558%
3.4109%
23.6323%
-1.8107%
-1.5543%
-6.4291%
-9.2189%
1.3941%
-8.7903%
-9.4154%
-36.9406%
-41.8658%
-49.8238%
-95.9883%
-35.6765%
-104.298%
-122.5046%
-176.26%
-169.088%
-80.0176%
-70.2654%
0.376%
0.0654%
4.6816%
13.1466%
16.8248%
21.5503%
31.2409%
31.2059%
33.2146%
26.444%
5.0122%
11.5588%
-9.087%
-25.3731%
-23.2932%
-20.3065%
-22.6923%
-38.0282%
-101.0471%
-148.9362%
-192.5234%
-184.8214%
-44.4444%
-71.0145%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.